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Abstract
Phosphorus plays vital roles in human health and nutrition. In nature, phosphorus
exists as phosphate, either inorganic or organic. The major form of phosphate in plant-
derived diets is phytate that cannot be degraded by monogastric animal, as well as
humans.  Initially,  this  chapter  reviews  current  research  of  phosphorus  in  human
nutrition and health. Subsequently, problems of phytate degradation and phosphorus
utilization in plant-derived diet are outlined. Next, as the main part, the enzymes of
phytase,  which  catalyze  the  release  of  inorganic  phosphorus  from  phytate,  are
compared, especially those produced by gut microbiota. Meanwhile, how probiotic
bifidobacteria can be used for producing phytase and therefore enhance their benefi‐
cial effects are discussed. Phytase-producing bifidobacteria can be either isolated rarely
in nature or constructed by genetic cloning of phytase genes from other well-charac‐
terized enzymes. The combination of bifidobacteria and highly active phytase may
improve human health and nutrition especially  as  supplementary probiotic  foods.
Therefore, potential application is prospected. Finally, other considerations related to
industrial production and usage of phosphorus-enriched additives are remarked. In
conclusion, improving and maintaining the phosphorus balance in food by bifidobac‐
teria may be promising for a healthier life.
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1. Introduction
Phosphorus is an essential nutrient for the body and is routinely consumed through food. After
consumption, phosphorus is usually bound with oxygen and exists as phosphate in the body.
Both organic and inorganic forms of phosphate are present in regularly consumed foods. The
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amount of total phosphate ingestion can be significantly influenced by processed food. Following
a meal, inorganic phosphate can be rapidly absorbed across the small intestine and enter the
bloodstream causing an elevation in serum phosphate levels. An increase in serum levels of
inorganic phosphate usually reduces serum levels of ionic calcium by forming a calcium
phosphate complex. High ratio of phosphate to calcium usually leads to hypophosphatemia.
In contrast, dietary phosphate deficiency, mostly due to malnutrition, can also impair the bone
mineralization process and eventually lead to the development of rickets [1]. Nevertheless,
phosphorus  homeostasis  is  important  for  versatile  functions,  especially  skeletal  growth,
development, and maintenance [2].
Despite the essential role of phosphate in living cells and wide application of phosphate
additives in kinds of food, humans cannot efficiently digest plant-derived phosphate, namely,
phytate that is the main form in both cereals and vegetables [3]. Degradation of phytate is
catalyzed by phytases, which are predominately presented on bacteria and fungi. Bifidobac‐
teria are the most frequently used microbial supplements in functional foods and probiotic
formulations [4]. Probiotics have many beneficial effects in human intestine [5]. Phytase
activity was detected in a few species of bifidobacteria [6,7]. Furthermore, heterologous
secretion of phytases cloned from other bacteria was reported in bifidobacteria as well [8].
These strains can be used in fermented foods for conversion of poorly digestible phytate
enriched in plant materials, which serves an alternative approach for dietary phosphorus
supplementation in humans, especially those health-compromised individuals.
2. Role of phosphorus in human nutrition and health
2.1. General biochemistry and distribution of phosphorus
In biological systems, phosphorus involves in many important reactions, including forming
cell membrane and nucleic acids, generation of ATP, cell signaling through protein phosphor‐
ylation or dephosphorylation, urinary buffering, and bone mineralization. In addition,
phosphorus widely takes part in biochemical reactions, e.g., glucose and triacylglycerol
(triglyceride) utilize phosphate to synthesize glucose 6-phosphate and glycerol 3-phosphate
respectively. Phosphorus is the sixth abundant element in the human body and comprises
approximately 1% of total body weight [9]. In mammals, phosphorus is presented as phos‐
phate, which is a predominantly intracellular anion. There is 85% phosphate in bone and
teeth, 14% in other tissues, and 1% in extracellular fluid.
Under steady state, a regular Western diet provides approximately 20 mg/kg/day of phos‐
phorus [10]. Around 16 mg/kg/day is absorbed in the proximal intestine, mainly in the jejunum.
The normal range of serum phosphate concentration is 4.5–8.3 mg/dl and higher in infants
who require more of the mineral for bone growth and soft tissue buildup [11]. At zero metabolic
balance, about 13 mg/kg/day phosphorus is excreted in the urine in adults. Thus, under
phosphate equilibrium state and normal renal function, the amount of urine phosphorus can
be an indicator of the amount absorbed in the intestine [12]. Reasonably, phosphate absorp‐
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tion and reabsorption decline along human aging, respectively, in both the intestinal tract and
kidney. Meanwhile, expression of sodium-phosphate co-transporters decreases [13].
2.2. Phosphorus for nutrition and health
Phosphorus can be supplied in two forms, namely, organic phosphate and inorganic phos‐
phate. Inorganic phosphate additives have greater bioavailability than organic sources of
phosphorus that are the main form of phosphate in plant-derived foods. Phosphorus serves
vital roles in the human body and is essential component of nutrient. It is crucial for bone
growth and mineralization. Both bench and clinical researches show that phosphate is one of
the major factors in the maintenance of bone health, and its deficiency results in bone pathology
and clinical illness, such as rickets and osteomalacia [14]. Inorganic phosphorus is one of the
two main ionic components required for hydroxyapatite formation during the mineraliza‐
tion of the extracellular matrix [15].
Roughly, 80–90% of the mineral content of bone is calcium and phosphorus, and 85% of the
phosphorus is in the skeleton. Adequate phosphorus intake is essential for skeletal minerali‐
zation. Although calcium plays an important role in regulating chondrocyte maturation,
apoptosis of hypertrophic chondrocytes is dependent upon circulating phosphate at normal
levels [16]. Diets high in phosphorus often lead to diminished intestinal calcium absorption,
reducing serum calcium concentration, and stimulating parathyroid hormone (PTH) secre‐
tion [17]. Phosphorus also directly regulates the production of 1,25(OH)2D by kidney cells.
Furthermore, phosphorus is considered to be a major dietary source of acid [18].
2.3. Phosphate homeostasis and health
As more than 2000 chemical reactions in living cells use phosphate, optimal phosphate balance
is essential for effective regulation. Generally, phosphate homeostasis is determined by both
intestinal absorption from consumed food and renal excretion of the serum phosphate.
Sodium-dependent phosphate (NaPi) transporters actively regulate the intestinal phosphate
absorption and partially mediate renal phosphate excretion and reabsorption as well.
Parathyroid hormone (PTH) facilitates urinary phosphate excretion because of strong
inhibition of NaPi transporters function [10]. Dietary phosphate restriction induces an
adaptive increase of intestinal phosphate uptake, and prolonged restriction increases NaPi-2a
activity, thereby attempting to restore the balance by increasing kidney phosphate reabsorp‐
tion [19].
The maintenance of optimal phosphate balance is managed by complex interactions be‐
tween the gut, kidney, and bone, as well as “phosphatonins” involving multiple regulators.
More precisely, the duodenum and jejunum are responsible for phosphorus absorption in the
diet via both passive diffusion and active sodium-dependent transportation [20]. The kidney
is the major organ involved in the regulation of phosphate homeostasis. A variety of factors
along the proximal convoluted and straight tubule of the kidney, including serum PTH,
calcium, 1,25(OH)2D3, and bicarbonate concentrations, take part in the regulation of phos‐
phate. In animals with intact parathyroid glands, the phosphate concentration in the proxi‐
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mal tubules is 70% of the plasma level. There is little phosphate reabsorption in the proximal
straight tubule in the presence of PTH. However, in the absence of PTH, phosphate is avidly
reabsorbed along the proximal straight tubule. As previously reported, phosphate renal losses
were enhanced by increasing fibroblast growth factor 23 (FGF-23).
2.4. Phosphate toxicity
Excessive retention of phosphate in the body is toxic to humans and can cause a wide range
of cellular and tissue injuries; partial toxicities are shown in Figure 1 [21]. Common toxicity of
phosphate in humans includes impaired renal function, rhabdomyolysis, and tumor lysis
syndrome [22]. Occasionally, exogenous phosphate toxicity is also documented in patients
when exposed to hypertonic phosphate enemas [23]. Horribly, excessive exogenous phos‐
phate administration can be fatal though the lethal dose in humans is unknown [24]. Overall,
it is convincingly demonstrated that phosphate accelerates various pathologies. Acute toxicity
can provoke hypocalcemia and associated symptoms including tetany, hypotension, and
tachycardia. Moderate toxicity leads to deposition of calcium phosphate crystals, including
often fatal cardiovascular calcification that usually irreversible. For instance, phosphate
toxicity has been implicated as independent risk factor for high mortality in chronic kidney
disease patients [25]. In an animal study, a 7–20-fold higher commercial phosphate-contain‐
ing enema induced 100% mortality [26]. In another study, the NaPi2a/klotho double-knock‐
out mice lost their fertility when fed with a high-phosphate diet [27]. Phosphate toxicity can
induce an increased rate of apoptosis in various tissues. It has been found that phosphate
toxicity accelerates the mammalian aging process by inflicting tissue damage and reducing
survival as well [28]. Meanwhile, several studies reported links between high dietary inor‐
ganic phosphate intake and cancer development [17,29], as well as bone health problems [10,
30].
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Figure 1. Partial list of pathological events related to phosphate toxicity composed by Razzaque [21] from related liter‐
atures in both human and animal studies.
3. Phytate in plant-derived diets
Phytate, the salt form of phytic acid, represents 60–80% of total phosphorus in plant seeds that
can be hydrolyzed by phytase. Even milk and its related products are the richest phosphate
sources in human diet; the major sources of phosphate in all natural foods are protein-rich
foods and cereal grains. However, humans do not encode genes for phytase and hence can
poorly digest phytate in plant-derived diets. Lacking of phytase causes three major prob‐
lems in simple-stomached animals as well as humans: (1) environmental pollution from
manure phosphorus, (2) dietary addition of inorganic phosphorus, and (3) depletion of rock
phosphorus deposits. For instance, in a crossover trial with chronic kidney disease-suffering
patients, the fasting serum phosphorus concentration was lower after the vegetarian diet than
after the meat diet that contained identical phosphorus. More notably, secretion of plasma
FGF-23 was about 40% lower in subjects treated with vegetarian diet after one week [31].
Phosphate interacts with several dietary minerals, such as calcium, sodium, and magnesium.
Therefore, deficiency of these minerals is more common than deficiency of phosphate when
its bioavailability is low. It was noted that the phosphorus bioavailability of natural foods is
variable. Particularly, the bioavailability of phosphorus in phosphate-rich plant foods such as
whole grains, legumes, peas, nuts, and seeds is relatively low, because a high proportion of it
is tied up in poorly absorbed phytates. Considering many studies link high phosphorus intakes
that are mainly supplied by inorganic phosphate additives to increased morbidity and
mortality, natural plant foods may favorite health outcomes as their relatively low bioavaila‐
bility of phosphorus.
4. Phytases and gut microbiota
Phytases (myoinositol hexakisphosphate phosphohydrolase) are enzymes that catalyze the
stepwise removal of phosphates from phytic acid (myoinositol hexakisphosphate) or its salt
phytate. Until now, a plenty of phytases were discovered and they show different catalytic
mechanisms. The first and most extensively studied group of phytases, such as Escherichia coli
AppA, belongs to the class of histidine acid phosphatases (HAPs) [32]. The other three groups
of phytase are classified as b-propeller phosphatase (BPP; also referred to as alkaline phy‐
tase, exampled by Bacillus amyloliquefaciens phytase) [33], protein tyrosine phosphatase (PTP;
also referred to as dual-specificity phosphatase) [34], and purple acid phosphatase (PAP;
metalloenzymes) [35]. Corresponding three-dimensional structures and catalytic sites of these
phytases are created using protein sequences. As shown in Figure 2, they have different
secondary structures together with different active sites [36]. The currently known distribu‐
tion of different types of phytases had been summarized in a previous review [3]. Among them,
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the majority are encoded by bacteria and fungi even a few species of animal and plant possess
phytase activity as well.
Figure 2. Secondary structure structures of representatives of each of the four structural classes of phytases. (A) Histi‐
dine acid phytase (HAPhy), (B) b-propeller phytase (BPPhy), (C) protein tyrosine phytase (PTPhy), and (D) purple acid
phytase (PAPhy). Pictures are adapted from the work done by Lei et al. [3].
Phylum Number Class
Proteobacteria 124 a-Proteobacteria (57)
b-Proteobacteria (4)
g-Proteobacteria (61)
Actinobacteria 39 Streptomycetales (20)
Micromonosporales (11)
Corynebacteriales (4)
Pseudonocardiales (3)
Bifidobacteriales (1)
Firmicutes 18 Bacillales (9)
Clostridiales (8)
Lactobacillales (1)
CFB group bacteria 7 Flavobacteriales (5)
Cyanobacteria 6 Gloeobacterales (4)
GNS bacteria 2
Dictyoglomales 2
BBPR_1292, which is annotated as lipoprotein in Bifidobacterium bifidum PRL2010, has two conserved domains that are
phytase-like or esterase-like (pfam13449) and NHL repeat unit of beta-propeller proteins (cl18310).
Table 1. Existence of phytase genes in bacteria.
The gut, especially the jejunum, is the most active site, responsible for the absorption of two
thirds of phosphate intake in humans. However, as mentioned above, gut cannot absorb
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organic phosphorus presented as phytate in plant-derived diets. We know that human gut
consists of a complex community of microorganisms, namely, gut microbiota. One main role
of gut microorganisms is they benefit the host by fermentation of human readily undigested
substrates to absorbable nutrients. Some gut microorganisms produce kinds of enzymes and
many of these enzymes are deficient in host, thereby symbiotic relationship is developed. Such
a case is phytase producing microbe, like Escherichia coli, Streptomyces coelicolor, Clostridi‐
um spp., and so on. Search of “phytase” in the NCBI gene database yielded 198 genes annotated
as bacterial phytase. A detailed presence of phytase genes in bacteria is demonstrated in
Table 1. Among them, Proteobacteria and Actinobacteria are the most predominating groups
that are also natural habitants of human gut.
5. Phytate degradation by bifidobacteria
5.1. Phytase-encoding genes
As shown in Table 1, there is only one gene in B. bifidum PRL2010 that was annotated as
possible phytase-encoding gene. Meanwhile, two enzymes in bifidobacteria, exactly B.
pseudocatenulatum ATCC 27919 and B. longum subsp. infantis ATCC 15697 with phytase
activity, have been characterized [37]. Therefore, protein sequences of these three enzymes
(BBPR_1292, BIFPSEUDO_03792, and BLON_0263) were used for searching homologues in
Bifidobacterium (taxid: 1678).
Organism  Protein name  Accession  Locus_tag  Length
(aa) 
B. dentium ATCC 27678 Histidine acid
phosphatase
WP_003838654 BIFDEN_01159  637
B. dentium ATCC 27679 Histidine acid
phosphatase
WP_003843340 HMPREF0168_2166 631
B. dentium Bd1 Histidine acid
phosphatase
WP_012902513 BDP_1985  643
B. longum DJO10A Histidine acid
phosphatase
WP_010081042 Blon03000750  617
B. longum DJO10A Histidine acid
phosphatase
WP_012472023 BLD_1202  622
B. longum NCC2705 Histidine acid
phosphatase
WP_011068470 BL0400  606
B. longum subsp. infantis 157F Histidine acid
phosphatase
WP_015713264 BLIF_0216  622
B. longum subsp. infantis ATCC
15697=JCM 1222
Histidine acid
phosphatase
WP_012576702 Blon_0263  623
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Organism  Protein name  Accession  Locus_tag  Length
(aa) 
B. longum subsp. infantis ATCC
15697=JCM 1222
Histidine acid
phosphatase
WP_014484530 BLIJ_0267  618
B. longum subsp. infantis CCUG 52486 Histidine acid
phosphatase
WP_007051528 BLIG_00414  617
B. longum subsp. longum 35B Histidine acid
phosphatase
WP_007057720 HMPREF1314_0451 572
B. longum subsp. longum 44B Histidine acid
phosphatase
WP_007056476 HMPREF1312_1349 617
B. longum subsp. longum BBMN68 Histidine acid
phosphatase
WP_013410389 BBMN68_1139  622
B. longum subsp. longum F8 Histidine acid
phosphatase
WP_015512490 BIL_17170  617
B. long um subsp. longum JCM 1217 Histidine acid
phosphatase
WP_007054753 BLLJ_0234  617
B. longum subsp. longum KACC 91563 Histidine acid
phosphatase
WP_014485906 BLNIAS_02473  617
B. pseudocatenulatum DSM 20438=JCM
1200
Histidine acid
phosphatase
WP_004222312 BIFPSEUDO_03792  639
B. sp. 12_1_47BFAA Histidine acid
phosphatase
WP_008783259 HMPREF0177_01170 561
Table 2. Protein list of histidine acid phosphatase in Bifidobacterium sp.*.
Available from http://www.ncbi.nlm.nih.gov/proteinclusters/?term=BIFPSEUDO_03792.
BLAST searches revealed that (1) BBPR_1292-like proteins are exclusively presented on the
genomes of all B. bifidum strains with at least 99% identity and (2) BIFPSEUDO_03792 and
BLON_0263 are presented in a few strains of Bifidobacterium. Though there is the presence of
BBPR_1292-like proteins, there is no specific phytase activity that had been detected in B.
bifidum. Based on sequence comparisons, these two characterized enzymes are more close to
the phytases of plants, fungi, and vertebrates. However, in the protein clusters database of
histidine acid phosphatase (PCLA_3557679), there are 18 proteins that belong to 16
bifidobacteria strains as listed in Table 2. Notably, all these predicted phytases belong to B.
dentium, B. longum, and B. pseudocatenulatum. Nevertheless, phytase activity has been detected
in some Bifidobacterium sp. even it is not a common metabolic feature.
5.2. Phytase enzyme activities
Initially, it was believed that bifidobacteria are phytase negative, as very low level activity may
be because of unspecific release by phosphatase, except B. pseudocatenulatum ATCC 27919 [6].
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To further evaluate the enzyme activities, five strains of different bifidobacterial species, i.e.,
B. animalis, B. bifidum, B. infantis, B. longum, and B. pseudolongum, were inoculated to degrade
myoinositol hexaphosphate (InsP(6)). In a complex medium in which phytic acid was the only
source of phosphorus, B. infantis ATCC 15697 showed the highest level of phytate-degrad‐
ing activity. The optimal condition is at slight acid pH (6.0–6.5) and higher temperature (50°C).
Maximum activity appears at the stationary phase of growth and when 1% lactose was used
as carbon source [7]. The same research team compared phosphatase and phytase activities
of 23 bifidobacterial strains (13 from infants and 10 from adults) belonging to three different
species (B. longum, B. breve, and B. catenulatum). The highest phytate-degrading activity is
displayed in B. longum BIF307, similar to previous comparison in which is B. infantis, a
subspecies of B. longum has the highest phytase activity.
Although two novel phytases from B. pseudocatenulatum and B. longum subsp. infantis had been
characterized, parallel comparison of bifidobacterial phytase activities to E. coli AppA is
difficult, as they were expressed as relative percentage activity. Nevertheless, the enzymes that
belong to a new subclass are highly specific for the hydrolysis of phytate and render
myoinositol triphosphate as the final hydrolysis product [37]. From our experience, native
phytase activity in bifidobacteria is extremely lower than commercial enzymes. Therefore, we
constructed a series of recombinant B. bifidum S17 that can secrete heterologous AppA within
high specific activity to phytate; even our primary aim is using appA as a suitable secretion
reporter [8]. Among these constructs, B. bifidum S17/pMgapS6P using the GAP promoter and
BBIF_1761 signal direct the most efficient phytase secretion (Figure 3).
Figure 3. Phytase activity in spent cell-free medium of recombinant B. bifidum S17 strains. B. bifidum S17-harboring
pMgapP-derived plasmids containing different SPs (S0–S6) were grown in 5 ml reinforced clostridia medium under
anaerobic condition. The control plasmid pMgapP (−) contains no SP and serves as a background control for expres‐
sion of a nonsecreted phytase. Values are relative phytase units (RPU) per ml supernatant and are mean ± standard
deviation of three independent cultures measured in technical triplicates. The figure is adapted from Osswald et al. [8].
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6. Potential application of phytase-producing bifidobacteria in foods
Despite phytase’s main application in animal feeds, its applications in human foods can be
equally important, if not exceed. To a large extent, using phytase in human foods is not
primarily the target to improve phosphorus consumption, because depletion of phytate is more
important as it chelates essential minerals, including iron, zinc, and calcium, contributing to
deficiencies of these nutrients. It was estimated that there are approximately two to three
billion people around the world suffering from mineral deficiency. The application of phytase
in human health may be more exciting but need further in-depth study of potential adverse
effects. Because certain inositol phosphates are beneficial to human health, phytase and
phytase-producing cells can be immobilized as cost-effective bioreactors for large-scale
production of these compounds [39]. There are many successful attempts to use phytase in
brewing, baking, and dephytination of soy milk [25].
In fact, application of phytase or phytase-producing bacteria in food has already been
illustrated. For example, B. pseudocatenulatum ATCC 27919 was tested as a starter in sour‐
dough for the production of whole rye-wheat mixed bread [40]. In situ production of phy‐
tase during fermentation by probiotics results higher mineral availability in breads. The ability
of B. infantis ATCC 15697 to degrade InsP(6) and accumulate InsP(3) could contribute to the
reduction of the anti-nutritional properties of InsP(6) and generation of intermediate com‐
pounds with beneficial properties. B. longum BIF307, another phytase producer, was used in
whole wheat bread making and decreased InsP(6) content. In another study, phytase-produc‐
ing bifidobacterial strains significantly reduced the InsP(6) + InsP(5) concentrations com‐
pared to control samples during the bread-making process. Meanwhile, dialyzable Fe contents
were increased from 2.3- to 5.6-folds. However, the effects appeared to be still insufficient to
improve Fe bioavailability in Caco-2 cells [41]. Anyway, with similar technological and
sensorial quality, levels of InsP(6) are significantly lower in bifidobacteria-fermented bread.
Collectively, probiotic bifidobacteria are particularly suitable to reduce the content of InsP(6)
in rich fiber products for human consumption [42].
7. Advantages of using phytase-producing bifidobacteria
One of the most important advantages of using phytase-producing bifidobacteria is safety. As
widely known, several species of bifidobacteria are generally regarded as safe (GRAS) or
qualified presumption of safety (QPS). The GRAS status made these strains particularly
attractive for application in both food and pharmaceutical industries. Currently, probiotic
bifidobacteria are widely used as micro-ecological reagent in many countries. These micro-
ecological reagents had been added into both foods and pharmaceuticals without additional
toxicity test.
Secondly, as important as the safety issue, many beneficial effects of bifidobacteria made them
promising in industry especially ameliorating gastrointestinal disorders (both bacterial- and
viral-induced gastroenteritis), allergic diseases, antibiotic-associated diarrhea, lactose
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intolerance, constipation, and irritable bowel disease. Let alone increasing iron accessibility,
phytase-producing bifidobacteria has expanded nutrition profile [41,42]. In the gut of human
eating plant-derived diets, phytase-producing bifidobacteria can degrade phytate-based
components, therefore improving their adaptability or cross-feeding other symbiotic inhabi‐
tants in the same niche.
Thirdly, intake of phytase-producing bifidobacteria is superior to eating inorganic phos‐
phate additives for human. In one aspect, phosphorus homeostasis can be easily disturbed
after eating external inorganic phosphate additives. In another aspect, phytase-producing
bifidobacteria can improve organic phytate-originated phosphorus. Thereby, supplementa‐
tion of external inorganic phosphate additives becomes unnecessary. This is particularly
significant for avoiding excessive phosphate, resulting in different kinds of toxicities that are
largely caused by phosphate-containing additives in foods and drinks. For example, phos‐
phorus-based food additives may pose high risk in people suffering chronic kidney disease,
as this made dietary management of hyperphosphatemia practically difficult. In dialysis
patients, managing hyperphosphatemia may require using phosphate binder other than
restricting protein intake as this allows patients to eat more protein-rich foods [43]. In addition,
a study evaluated 93 premature infants with a mean gestational age of 27.5 ± 2.0 weeks. The
result demonstrated that elevated serum phosphorus was inversely correlated to the day of
life of the infant after receiving human milk-derived fortifier though the incidence of hyper‐
phosphatemia was mild and transient in this population [44]. For those health promised
people, intake of phytase-producing bifidobacteria supplied a novel interventional approach.
Lastly but not least, bifidobacteria can produce phytase in human gut as microbial cell factories.
They can be ingested as live cells and then colonized in the intestine to facilitate the degrada‐
tion of plant-derived diets. The relatively constant replication of bifidobacteria in human
intestine can either enlarge the bioavailability of organic phytate or downsize the toxicity of
excessive phosphorus, hence maintaining the balance of phosphorus in a long term.
8. Final remarks
Phosphorus salts are added to foods as additives in many countries. Thus, dietary intake of
phosphorus is higher than the recommended daily allowance in these countries and popula‐
tions. For instance, phosphorus additives were particularly common in the categories of small
goods, bakery goods, frozen meals, and biscuits in Australia [45]. In the United States, it has
been estimated that phosphorus additives may add as much as 1 g of phosphorus to the diet
[46]. However, high phosphorus intake has been shown to inhibit the increase in serum
1,25(OH)2D concentration in response to low dietary calcium intake [30].
Collectively, although long-term and large amount consumption of phosphorus additives,
little is known about risk associated with dietary phosphorus intake. A prospective cohort
study of healthy adults reveals that high dosage of dietary phosphorus intake is associated
with increased mortality [47]. Considering that the deleterious effects of chronic ingestion of
unrestricted amounts of phosphate in individuals are not clear, consumption of high phos‐
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phate-containing processed foods and soft drinks should be alarming, particularly for health-
compromised individuals [48,49]. Under those circumstances as mentioned above, using
phytase-producing bifidobacteria may be a new way for increasing bioavailability of phos‐
phorus from plant-derived diets, therefore avoiding supplementation of inorganic additives.
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